Quinn Opportunity Partners’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding VIGL
Quinn Opportunity Partners's VIGL Position: Q3 2025 in Review
Quinn Opportunity Partners sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 450,000 shares — an estimated $3.58M sold.
Quinn Opportunity Partners first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $3.58M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.
- Quinn Opportunity Partners reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
- Quinn Opportunity Partners sold 450,000 Vigil Neuroscience shares in Q3 2025, an estimated $3.58M.
- Quinn Opportunity Partners first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
- Quinn Opportunity Partners's Vigil Neuroscience position peaked at $3.58M in Q2 2025.
- 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.
Based on Quinn Opportunity Partners's 13F filing for Q3 2025, filed 13 Nov 2025.